Clinical Trial Update: Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL [NA]

View source ↗

Summary

A clinical trial is recruiting for an integrated radiotherapy-optimized ASCT sequential CAR-T therapy for relapsed or refractory aggressive B-cell non-Hodgkin l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aggressive B-cell Non-hodgkin Lymphoma

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL) | NA | Status: RECRUITING